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The RNA-dependent protein kinase PKR plays important roles in the antiviral and antiproliferative actions of IFN. The
IFN-inducible promoter of the human PKR gene contains a 15-bp DNA element designated KCS. The KCS element is located
4 bp upstream of the interferon-stimulated response element (ISRE) and is required for both basal and IFN-inducible
transcription. We have examined the effect of insertion mutations between the KCS and the ISRE elements, as well as altered
orientation of the KCS element relative to the ISRE element, to assess a possible functional interaction between them. Large
insertions (93 bp) between the KCS and ISRE elements significantly reduced both basal and IFN-inducible promoter activity.
The function of the KCS element was dependent on the orientation of KCS relative to the ISRE element. Multimerization of
the KCS element increased both basal and IFN-inducible transcription. Electrophoretic mobility shift analyses (EMSA)
identified IFN-inducible protein complex formation that required both the KCS and the ISRE DNA element sequences. The
novel IFN-inducible protein complexes contained the transcription factor STAT1, as shown by supershift analyses and by their
/INTRODUCTION
Interferons (IFN)2 are a family of cytokines that pos-
sess antiviral activity. Among the cellular proteins in-
duced by IFN is the RNA-dependent protein kinase PKR
(Samuel, 1979; Meurs et al., 1990). PKR is an important
regulator of translation in interferon-treated and virus-
infected cells. The PKR kinase catalyzes the phosphor-
ylation of the  subunit of eukaryotic protein synthesis
initiation factor 2 on serine residue 51, a modification that
leads to inhibition of mRNA translation (Samuel, 1993;
Gale et al., 2000). Inhibition of mRNA translation medi-
ated by PKR plays an important role in the antiviral
actions of IFN (Clemens and Elia, 1997; Samuel, 2001).
PKR also phosphorylates the NF-B inhibitor I-B (Maran
et al., 1994), which leads to activation and nuclear trans-
location of NF-B (Thanos and Maniatis, 1995). Further-
more, PKR regulates transcriptional activation mediated
by the p53-tumor suppressor (Cuddihy et al., 1999) and
modulates cytokine signaling and transcriptional activa-
tion via STAT factors (Wong et al., 1997). As a result, PKR
has been implicated in a variety of biological processes
including the control of cell growth, apoptosis, and dif-
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136ferentiation in addition to its role in the antiviral actions of
interferons (Lengyel, 1993; Clemens and Elia, 1997; Biron
and Sen, 2001; Samuel, 2001). The activity of PKR is
regulated at multiple levels, including inhibition of PKR
protein synthesis by autoregulation, posttranslational ac-
tivation of PKR kinase activity as a result of RNA-depen-
dent autophosphorylation, modulation of kinase activity
by homo- and heteromeric protein–protein interactions,
and transcriptional induction of the PKR gene by type I
IFNs (Barber et al., 1993a; Cosentino et al., 1995; Ortega
et al., 1996; Gale et al., 2000; Biron and Sen, 2001;
Samuel, 2001).
The structural organization of both the human and the
murine PKR genes has been determined; the 5 flanking
sequences of both contain a functional TATA-less pro-
moter (Tanaka and Samuel, 1994, 2000; Kuhen and Sam-
uel, 1997, 1999). The human PKR gene spans approxi-
mately 50 kb on chromosome 2p and consists of 17
exons that specify a 551 amino acid protein (Barber et al.,
1993b; Kuhen et al., 1996). The promoter region includes,
in addition to a 13-bp interferon-stimulated response
element (ISRE) responsible for the type I IFN-inducibility,
a novel 15-bp element designated KCS for kinase con-
served sequence (Kuhen and Samuel, 1997). The KCS
element functions as a constitutive activator element. It
is required for both optimal basal and IFN-inducible
promoter activity (Kuhen et al., 1998). The sequence andpresence in extracts prepared from STAT1 wild-type but no
suggest that the KCS and ISRE elements of the human PKR
shift assay; IFN, interferon; PKR, the RNA-dependent eIF-2 protein
kinase inducible by interferon; PKR, gene encoding the PKR kinase.
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position of the KCS element relative to the ISRE are
exactly conserved in the human and murine PKR promot-t from
prom
ers; the two elements are separated from each other by
4 bp (Kuhen and Samuel, 1997).
The role of the ISRE element in IFN-mediated signal-
ing and transcriptional activation of cellular gene expres-
sion is best understood in the context of the Jak-STAT
pathway of signal transduction (Stark et al., 1998; Sam-
uel, 2001). For the - and -IFNs, phosphorylated forms
of STAT1 and STAT2 along with the non-STAT IRF-9 con-
stitute a trimeric protein complex known as ISGF-3 that
binds the ISRE element (Schindler et al., 1992; Schindler
and Darnell, 1995). In contrast to the inducible ISGF-3
protein binding of ISRE elements, the KCS element me-
diates constitutive protein binding consistent with its
function as a constitutive activator element. A major
complex designated KBP for KCS binding proteins has
been identified and shown to contain the transcription
factor Sp1 (Kuhen and Samuel, 1999). Both the 5 and the
3 halves of the 15-bp KCS element are capable of me-
diating protein binding, and both basal and IFN-inducible
promoter activity are severely reduced by point muta-
tions within the 5 and 3 halves of the KCS element that
reduce KBP complex formation (Kuhen et al., 1998; Kuhen
and Samuel, 1999). Binding of the Sp1 factor is localized
to the 5 half of KCS (Kuhen and Samuel, 1999). The
identity of other protein members of the KBP complex
and their possible interaction with proteins bound at the
ISRE element are unknown. Indeed, the possibility that
protein binding and complex formation may require the
presence of both the KCS and the ISRE elements has not
been examined.
Because of the conservation of KCS element position
and function, and the proximity of the ISRE and KCS
elements relative to each other, we examined the effect
of variable-sized insertions between the KCS and the
ISRE elements on human PKR promoter activity. In addi-
tion, the effects of reversing the orientation of KCS rela-
tive to the ISRE element and KCS element multimeriza-
tion were evaluated. Finally, we searched for novel pro-
tein complexes that require the presence of both the KCS
and the ISRE DNA elements and IFN- treatment for their
formation.
RESULTS
Increased spacing between the KCS and ISRE
elements reduces PKR promoter activity
To determine whether or not the distance between the
KCS and the ISRE elements affected promoter activity,
insertional mutants with altered spacing between KCS
and ISRE were generated. The parent construct used,
the p63 minimal PKR promoter, possesses only the KCS
and ISRE elements and a short natural sequence down-
stream of the ISRE (Kuhen and Samuel, 1997). Shown in
Fig. 1A is an autoradiogram that illustrates the promoter
activities obtained with insertional mutants. Chloram-
phenicol acetyltransferase (CAT)-reporter results repre-
senting the average of at least three independent tran-
sient transfection experiments are shown in Fig. 1B.
Insertion of 11 bp between KCS and ISRE to give a
total of 15 bp of spacing between the elements only
slightly reduced promoter activity compared to the wild-
type construct p63 (Wt) with the natural spacing of 4 bp
(Figs. 1A and 1B). However, insertion of 93 and 181 bp
between the KCS and the ISRE elements to give a total
separation of 97 and 185 bp, respectively, drastically
reduced both basal and IFN-inducible transcription.
Spacer sequences taken from the bacterial plasmid vec-
tor pBluescript were chosen that minimized homology
with known functional eukaryotic elements and that
lacked homology to the KCS element. Because the
spacer sequences of the constructions possessing in-
sertions of 93 bp or more were different, it seems unlikely
that the sequence per se of the inserted DNA was re-
sponsible for the reduction of promoter activity seen
rather than the increased physical separation between
the KCS and the ISRE elements. Furthermore, insertions
greater than 93 bp between KCS and ISRE reduced
promoter activity below that observed for the KCS dele-
tion mutant. This suggests the possibility that proteins
bound at the distant KCS element were sequestered in a
functionally impaired manner, for example, that pre-
cluded proper interaction with either specialized proteins
bound at the ISRE element or with general components
of the transcriptional machinery.
Reversing the orientation of the KCS element reduces
PKR promoter activity
The orientation as well as position of the KCS element
relative to the ISRE element are conserved in the human
and mouse PKR promoters (Tanaka and Samuel, 1994;
Kuhen and Samuel, 1997). To determine the effect of
reversed orientation of the KCS element relative to the
ISRE element, the orientation of KCS was reversed in the
background of a minimal human PKR promoter construct
that contained 15 bp of spacing between KCS and ISRE.
The activity of this p63 (revKins11I) construct in transient
transfections was compared to that of the wild-type p63
(Wt) construct and mutant constructs possessing either
15 bp of spacing between KCS and ISRE with the KCS
element in the natural orientation [p63 (Kins11I)] or lack-
ing the KCS element [p63 (delK)]. As shown in Fig. 2,
whereas introduction of 15 bp of spacing alone only
slightly affected basal and IFN-inducible transcription,
reversing the orientation of KCS in the background of 15
bp of spacing greatly reduced both basal and IFN-induc-
ible promoter activity. The low activity seen with the p63
(revKins11I) mutant was comparable to that of the KCS
deletion p63 (delK) mutant (Fig. 2). These results, taken
together with those shown in Fig. 1, suggest that the
function of the KCS element is dependent upon both
position and orientation relative to the ISRE.
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Multimerization of the KCS DNA element increases
both basal and IFN-inducible promoter activity
The human and mouse PKR promoters both contain a
single copy each of the KCS element and the ISRE
element. Previous studies revealed that duplication of
both elements (KCS and ISRE) as a unit did not result in
increased IFN-inducible promoter activity, although
basal promoter activity was increased significantly and
approached levels comparable to the IFN-induced activ-
ity (Kuhen and Samuel, 1999). Based on these observa-
tions, we tested the effect of multimerization of wild-type
and mutant forms of the KCS element in the context of a
single ISRE element. CAT-reporter constructs containing
FIG. 1. Increased spacing between the KCS and ISRE elements reduces basal and IFN-inducible PKR promoter activity. (A) Representative autoradiogram
illustrating promoter activities obtained in human amnion U cells transfected with the indicated CAT-reporter plasmids containing insertion mutations
generated in the minimal human PKR promoter construct p63 (Wt) that includes the KCS and ISRE elements. The p63 (delK) construct which lacks the KCS
element, but possesses a functional ISRE element, was also included in transfection analyses. Cells were left untreated or treated with IFN- for 24 h. To control
for transfection efficiency, cells were cotransfected with the pGL2-Control plasmid as an internal reference. The promoterless plasmid vector pCAT-Basic served as
a negative control in all transfection experiments. pCAT-Control, in which CAT-reporter gene expression is driven by the simian virus 40 promoter and enhancer,
served as a positive control. (B) Quantitation of CAT-reporter results obtained from at least three independent transfections. Shown on the left is a
schematic representation of CAT-reporter plasmids; the right side shows the promoter activities observed. Open bars refer to cells left untreated, and
hatched bars refer to cells treated with IFN- for 24 h. Relative promoter activity is shown normalized to basal activity of the p63 (Wt) construct.
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a single ISRE element, and either no, one, or three KCS
elements in the background of the parent p63 (Wt) plas-
mid were analyzed in human amnion U cells (Fig. 3). Both
basal and IFN-inducible promoter activities were sub-
stantially increased for the p63 (insKx2) construction that
possesses three copies of the wild-type KCS element
(Fig. 3, lane 4) relative to the p63 (Wt) parent with one
copy of KCS (lane 2).
Analysis of a family of KCS substitution mutants, in-
cluding the mt6A and mt9T mutants, indicated that both
the 5 and the 3 regions of the KCS element were
required for basal and IFN-induced promoter activity
(Kuhen et al., 1998). The 5 half of KCS mediates binding
of the transcription factor Sp1; the identity of proteins
binding to the 3 half of KCS remain unknown (Kuhen and
Samuel, 1999). To assess the contributions of the 5 and
3 halves of the KCS element to the increased promoter
activity observed following KCS multimerization, a series
of mutant constructs were prepared in which each of the
KCS repeats in the background of p63 (insKx2) was
mutated (Fig. 3). Consistent with previous results, intro-
duction of either the 6A (Fig. 3A) or the 9T (Fig. 3B) point
mutation into the single KCS DNA element of the parent
p63 (Wt) construct greatly reduced both basal and IFN-
induced promoter activity to low levels. Analysis of pro-
moter constructions containing one mutant KCS element
and two wild-type KCS elements, along with a single
wild-type ISRE element, revealed that introduction of
either the 6A (Fig. 3A) or the 9T (Fig. 3B) mutation re-
duced promoter activity. Mutation of either the most 5
positioned copy or the middle copy of the KCS element
caused greater reductions in both basal and IFN-induc-
ible promoter activity than mutation of the KCS element
copy positioned immediately adjacent to the ISRE ele-
ment (Fig. 3). These results suggest that both half-sites of
KCS play a role in the elevated promoter activity seen
following multimerization of the KCS element.
Protein binding to the KCS and ISRE elements of the
PKR promoter
Our analyses of reporter gene expression in trans-
fected cells suggest that the KCS and ISRE DNA ele-
ments likely may behave as a functional unit. As one
approach to further assess this possibility, we examined
protein binding to the ISRE element alone (I-probe) and
to both the KCS and the ISRE elements present together
in the same fragment of DNA (KI-probe). EMSA analyses
were performed using nuclear extracts prepared from
untreated and IFN-treated mouse embryo fibroblast
(MEF) cells, either wild-type or mutant lacking the STAT1
transcription factor (Figs. 4–6). Consistent with well-es-
tablished observations for IFN-inducible genes (Schind-
ler and Darnell, 1995; Stark et al., 1998), selective protein
FIG. 2. KCS function is dependent on the orientation of KCS relative to the ISRE in the context of 15 bp of spacing between the elements. The left
side is a schematic representation of wild-type and mutant CAT-reporter constructs encompassing the minimal human PKR promoter region that
contains the KCS and ISRE elements. The p63 (delK) construct was as described under the legend for Fig. 1 and was included in transfections for
the purpose of comparison. Shown on the right are the promoter activities observed in human amnion U cells transfected with the indicated wild-type
and mutant reporter plasmids. Open bars refer to cells left untreated, and hatched bars refer to cells treated with IFN- for 24 h. Results are shown
as relative promoter activities normalized against basal promoter activity of the p63 (Wt) construct. The pGL2-Control plasmid served as an internal
reference to control for transfection efficiency. pCAT-Basic is as described under the legend for Fig. 1.
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binding to the ISRE element of the PKR promoter was
dependent on IFN treatment (Fig. 4, lanes a and b, and
Fig. 5, lanes a and b). The induced band likely corre-
sponds to ISGF-3 (Fu et al., 1990; Schindler et al., 1992)
as determined by supershift analysis using an antibody
which recognizes STAT1/ (Fig. 5, lane f), and by its
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absence when extracts prepared from STAT1/ mutant
null cells were used (Fig. 6, lane j). A 100-fold molar
excess of either unlabeled KI-oligonucleotide (Fig. 5,
lane c) or I-oligonucleotide (Fig. 5, lane d) efficiently
competed formation of the ISGF-3 complex. By contrast,
a 100-fold molar excess of unlabeled K-oligonucleotide
did not detectably affect ISGF-3 complex formation (Fig.
5, lane e).
In an attempt to detect the possible existence of novel
protein complexes that might require both the KCS and
the ISRE elements for their formation, EMSA analysis
was carried out with a KI-probe (Fig. 4, lanes c and d, and
Fig. 5, lanes h–p). In the absence of IFN treatment,
significant bandshift complex formation was seen with
the KI-probe (Fig. 4, lane c, and Fig. 5, lane h). The major
complex formed, designated KBP, was not enhanced
with nuclear extracts from IFN-treated cells (Fig. 4, lane
d, and Fig. 5, lane i) as compared to untreated cells (Fig.
4, lane c, and Fig. 5, lane h). A similar major KBP complex
was observed with a KCS element K-probe alone inde-
pendent of IFN treatment (Kuhen and Samuel, 1999; data
not shown). However, treatment with IFN did cause the
formation of a novel complex seen with the KI-probe,
designated iKIBP1 for inducible KCS/ISRE binding pro-
tein complex (Fig. 4, lane d). A minor second inducible
novel complex (designated iKIBP2) of slightly faster mo-
bility was also observed (Fig. 4, lane d). The iKIBP com-
plexes were not seen with extracts from untreated cells
(Fig. 4, lane c). Similar patterns of bandshift complex
formation and competition profiles were obtained for
whole-cell extracts as compared to nuclear extracts pre-
pared from either untreated or IFN- primed, IFN--
treated cells when analyzed with the KI-probe (data not
shown). The pattern of bandshift complex formation was
similar with unprimed and primed (IFN- or IFN-A/D)
cells subsequently treated with the higher dose of IFN-
A/D. However, less inducible complex was seen in the
absence of priming, and the amount of complex was
greater following priming with IFN- compared to IFN-
A/D, consistent with prior reports (Levy et al., 1990).
Competition analyses revealed that a 100-fold molar
excess of unlabeled KI-, I-, or K-oligonucleotide was able
to compete the formation of iKIBP complexes with 32P-
labeled KI-probe (Fig. 5, lanes j–l, and Fig. 6, lanes e–g).
However, excess unlabeled I-oligonucleotide did not
compete KBP complex formation (Fig. 5, lane k, and Fig.
6, lane f), and excess unlabeled K-oligonucleotide did not
compete formation of the ISGF-3 complex (Fig. 5, lane l,
and Fig. 6, lane g), demonstrating that the KCS and ISRE
elements bind distinct protein factors.
Further competition analyses revealed that iKIBP com-
plex formation was highly specific. The single KCS sub-
stitution mutants mt6A and mt9T earlier had been dem-
onstrated to be transcriptionally inactive (Kuhen et al.,
1998). Neither the KCS(mt6A) mutant (Fig. 5, lane m, and
Fig. 6, lane h) nor the KCS(mt9T) mutant (Fig. 5, lane n)
oligonucleotide when used as the unlabeled competitor
was able to compete the formation of the iKIBP1 com-
plex. By contrast, the wild-type KCS competitor (Fig. 5,
lane l, and Fig. 6, lane g) abolished iKIBP complex for-
mation. The KCS(mt6A) and KCS(mt9T) competitors also
were unable to compete KBP complex formation with the
KI-probe (Fig. 5, lanes m and n), similar to prior findings
with the K-probe (Kuhen and Samuel, 1999). The obser-
vation that the formation of the inducible iKIBP com-
plexes was able to be competed by addition of unlabeled
KCS wild-type oligonucleotide is consistent with previ-
ous findings that two or more proteins or protein com-
plexes selectively bind at the KCS element (Kuhen and
Samuel, 1999).
FIG. 4. Detection of protein binding to the KCS and ISRE elements by
electrophoretic mobility shift assay (EMSA). Protein complexes were
detected in nuclear extracts (10 g of protein) prepared from untreated
or IFN-A/D treated mouse embryo fibroblast (MEF) cells. Priming with
IFN-A/D was at 100 U/ml for 18 h, followed by treatment with IFN-A/D
at 1000 U/ml for 30 min. EMSA was carried out using 32P-labeled
synthetic dsDNA oligomer probes possessing only the ISRE element
(I-oligonucleotide; lanes a, b) or both the KCS and the ISRE elements
(KI-oligonucleotide; lanes c, d) of the human PKR promoter. The KBP,
ISGF-3, and iKIBP complexes are indicated by arrows.
FIG. 3. Both the 5 and the 3 halves of the KCS element are required for increased promoter activity that results from KCS element multimerization.
(A) Analysis of CAT-reporter constructions containing the point mutation 6A that affects the 5 half of the KCS element. (B) Analysis of CAT-reporter
constructions containing the point mutation 9T that affects the 3 half of the KCS element. The left side of (A) and (B) is a schematic representation
of wild-type and mutant CAT-reporter constructs possessing a single KCS element or three KCS elements. Point mutations 6A or 9T are depicted by
the solid oval above the KCS element. The p63 (Wt) and p63 (delK) constructs were as described under the legend for Fig. 1. Shown on the right of
(A) and (B) are the promoter activities observed in human amnion U cells transfected with the indicated wild-type and mutant reporter plasmids. Open
bars refer to cells left untreated, and hatched bars refer to cells treated with IFN- for 24 h. Results are shown as relative promoter activities
normalized against basal promoter activity of the p63 (Wt) construct. The pGL2-Control plasmid served as an internal reference to control for
transfection efficiency. pCAT-Basic is as described under the legend for Fig. 1.
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STAT 1 is a component of the iKIBP1 and iKIBP2
complexes
To determine whether the STAT1 factor is required for
formation of the novel iKIBP complexes, two types of
experiments were performed. First, supershift analysis
was performed using the same anti-STAT1 antibody that
did supershift the ISGF-3 complex formed with the I-
probe (Fig. 5, lane f). This antibody did not affect the
major KBP complex seen with the KI-probe (Fig. 5, lane
o). However, addition of the anti-STAT1 antibody abol-
ished formation of the iKIBP1 complex (Fig. 5, lane o).
Overexposure of the autoradiogram revealed that forma-
tion of the iKIBP2 complex also was abolished by addi-
tion of anti-STAT1 antibody (data not shown). Three su-
pershift complexes were observed; the major supershift
complex likely corresponded to supershifted ISGF-3. The
two minor supershift complexes observed had similar
yet distinct mobilities as compared to the iKIBP com-
plexes. These results suggest that STAT1 is a component
of the novel iKIBP complexes.
To independently test whether STAT1 was required for
formation of the iKIBP1 and iKIBP2 complexes, nuclear
extracts from mutant STAT1/ null MEF cells and wild-
type MEF cells were compared by EMSA analysis (Fig.
6). Cell extracts that contained wild-type STAT1 showed
IFN-dependent formation of the ISGF-3 complex with
both the I-probe (Fig. 6, lanes a and b) and the KI-probe
(Fig. 6, lanes c and d). As expected, the ISGF-3 complex
was not observed with extracts from STAT1/ null cells,
with either the I-probe (Fig. 6, lanes i and j) or the
KI-probe (Fig. 6, lanes k and l). Likewise, iKIBP complex
formation was not detected with extracts from IFN-
treated STAT1/ null cells (Fig. 6, lane l compared to
lane d). By contrast, formation of the KBP complex with
the KI-probe was not detectably reduced with extracts
from STAT1/ null cells as compared to extracts pre-
pared from wild-type MEF cells, either untreated (Fig. 6,
lanes c and k) or IFN-treated (Fig. 6, lanes d and l).
Unlabeled ISRE oligonucleotide did not compete for-
mation of the KBP complex observed with extracts from
both wild-type or STAT1/ null cells using the 32P-la-
beled KI-probe (Fig. 6, lanes f and n). Likewise, unlabeled
KCS mutant mt6A oligonucleotide also did not compete
either iKIBP complex formation or KBP complex forma-
tion (Fig. 6, lanes h and p). Unlike STAT1 wild-type MEF
cell extracts where ISGF-3 was seen in the presence of
unlabeled wild-type KCS oligonucleotide competitor (Fig.
6, lane g), no bandshift complex corresponding to ISGF-3
was detected with STAT1/ null cell extracts in the
presence of K competitor that eliminated formation of
KBP (Fig. 6, lane o). These results firmly establish the
STAT1 protein as a component of the novel inducible
iKIBP complexes.
FIG. 5. Competition analysis of protein complex formation at the ISRE element alone and the KCS element together with the ISRE. EMSA was carried
out as described under the legend for Fig. 4 using the I-oligonucleotide (lanes a-g) or the KI-oligonucleotide (lanes h-p) as probe. Nuclear extracts
from untreated (lanes a, h) or IFN-A/D treated cells (lanes b–g and lanes i–p) were incubated with 32P-labeled oligomer probe in the absence of
competitors (lanes a, b and h, i) or in the presence of the indicated competitor oligomer (lanes c–e and j–n). Supershift analyses were carried out
using polyclonal antibodies against STAT1/ (lanes f, o) and CBP (lanes g, p). The KBP, ISGF-3, and iKIBP complexes are indicated by arrows.
FIG. 6. The STAT1 transcription factor is a component of the novel
iKIBP complexes. EMSA analysis was carried out with nuclear
extracts prepared from STAT1 wild-type MEF cells (lanes a–h) and
STAT1 null MEF cells (lanes i–p). The 32P-labeled I- (lanes a, b and
i, j) and KI-oligonucleotides (lanes c–h and k–p) were as described
under the legend for Fig. 4 and used as the dsDNA oligomer probes;
10 ug nuclear extract from untreated (lanes a, c, i, k) or IFN-A/D-
treated (lanes b, d–h, j, l–p) cells was analyzed with the I- and
KI-oligonucleotide probes in the absence of competitor (lanes a–d
and i–l) or in the presence of the indicated competitor oligomer
(lanes e–h and m–p). Treatment of cells with IFN-A/D was as
described under the legend for Fig. 4. The KBP, ISGF-3, and iKIBP
complexes are indicated by arrows.
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CREB binding protein is not a component of the iKIBP
complexes
Interaction between STAT1 and the transcription factor
CBP, which possesses intrinsic histone acetylase activ-
ity, has been reported (Zhang et al., 1996; Horvai et al.,
1997). In addition, transcriptional activation mediated by
Sp1 has been shown to occur in concert with CBP (Na¨a¨r
et al., 1998; Owen et al., 1998). We therefore considered
whether CBP might be a component of iKIBP1 or iKIBP2,
because Sp1 earlier was identified as a component of
the major KBP complex (Kuhen and Samuel, 1999) and
because ISGF-3 was able to bind the ISRE element
present in the PKR promoter immediately downstream of
the KCS element (Figs. 5 and 6). However, antibody
against CBP did not affect the bandshift complexes
formed with the KI-probe or the I-probe (Fig. 5, lanes g
and p), although the same anti-CBP antibody readily
detected CBP by Western analysis (data not shown) of
the nuclear extracts used for the EMSA tests. Under
similar conditions, antibody against either STAT1 (Fig. 5,
lanes f and o) or Sp1 (Kuhen and Samuel, 1999; data not
shown) altered complex mobility.
DISCUSSION
The PKR kinase plays a role in several important
physiological responses, ranging from the antiviral ac-
tions of interferons to the regulation of cell growth and
apoptosis (Biron and Sen, 2001; Samuel, 2001). Our study
was undertaken to gain insight into the function of the
novel KCS DNA element that is necessary for basal and
IFN-inducible transcription driven by the TATA-less PKR
promoter. Several important points emerge from our re-
sults reported herein.
First, the function of the KCS element was dependent
on the position relative to the ISRE element. Although
relatively small changes in the distance between the
KCS and ISRE elements such as 4 bp (Kuhen and Sam-
uel, 1999) or 11 bp (this study) did not significantly affect
either basal or IFN-inducible promoter activity, greater
separation of the two elements illustrated by the 93 or
181 bp insertions drastically reduced transcriptional ac-
tivity. At the larger distance of separation, the PKR pro-
moter activity fell to levels below that seen by deletion of
the KCS element. These observations are consistent with
the existence of proteins that bind at the KCS element
and also interact functionally with specialized transcrip-
tional activators bound at the ISRE element or possibly
with general transcription factors. A possible role of KCS
binding proteins in an interaction with the general tran-
scriptional machinery is supported by the finding that the
KCS element functions as a constitutive activator ele-
ment and that mutations affecting either the sequence or
the position of the KCS element mediated comparable
effects on both basal and IFN-inducible transcription of
the PKR gene.
Second, the function of the KCS element was depen-
dent on the orientation relative to the ISRE element. This
was clearly established using the small 11-bp insertion
mutant. Reversing the orientation of the KCS element in
this context markedly decreased both basal and IFN-
inducible promoter activity to a low level similar to that of
the KCS element deletion mutant, suggesting the com-
plete loss of KCS function under these conditions.
Third, multimerization of the KCS element substantially
increased both basal and IFN-inducible transcription
when tested in the presence of a single ISRE. However,
the fold transcriptional induction by IFN seen either with
three copies of the KCS element or without any copies of
KCS was similar to that of the wild-type construct pos-
sessing only a single copy. This is in contrast to results
obtained when both KCS and ISRE were duplicated as a
unit. With two copies of both the KCS and the ISRE, basal
transcriptional activity was increased to a level compa-
rable to that seen in IFN-treated cells (Kuhen and Sam-
uel, 1999). The increase in basal as well as IFN-inducible
promoter activity observed when the KCS element was
multimerized further suggests that proteins bound at the
KCS element might possibly interact both with proteins
bound at the ISRE element or with proteins that consti-
tute the general transcription machinery. In the latter
capacity, conceivably the KCS element is directly in-
volved in recruitment of general transcription factors. The
Sp1 transcription factor, a constituent of the KBP com-
plex (Kuhen and Samuel, 1999), has been reported to
interact with a component of TFIID and to function in
the recruitment of the general transcription machinery
(Lemon and Tjian, 2000). In addition, TFIID is required for
transcriptional activation mediated by Sp1 (Smale et al.,
1990; Gill et al., 1994; Lemon and Tjian, 2000). Both the 5
and the 3 halves of the KCS element are required for
maximal increase in promoter activity. Both the 5 and
the 3 halves of the 15-nt KCS element were shown to be
capable of specific protein binding; single-point muta-
tions affecting either half of the element resulted in both
greatly reduced basal and IFN-inducible transcriptional
activity (Kuhen et al., 1998; this study).
Finally, protein binding occurred simultaneously at
both the KCS and the ISRE DNA elements in vitro. This is
consistent with the notion that the KCS and ISRE ele-
ments may function in concert with each other. Following
IFN treatment which resulted in the binding of ISGF-3 at
the ISRE element (Fu et al., 1990; Schindler et al., 1992),
protein binding at the KCS element was not detectably
altered using a probe that contained both the KCS and
the ISRE elements. Conversely, protein binding at the
KCS element did not preclude formation of the ISGF-3
complex at the ISRE element. Most importantly, novel
IFN-inducible complexes designated iKIBP specifically
bound to a KI-probe that contained both a wild-type KCS
and a wild-type ISRE element. Either KCS alone or ISRE
alone was able to compete iKIBP complex formation,
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suggesting a requirement of both the KCS and the ISRE
element sequences and their bound transcriptional acti-
vators.
Interestingly, the transcription factor STAT1 was found
to be a component of the iKIBP complexes. In light of our
results obtained from reporter and EMSA analyses, as
well as previous studies demonstrating direct interaction
of the transcriptional activator Sp1 with STAT1 in the
context of adjacent GC-box and GAS elements of the
ICAM-1 gene promoter (Look et al., 1995), it is tempting
to speculate that direct protein–protein interactions oc-
cur between KBP complex components and STAT1
present as part of the ISGF-3 complex bound at the ISRE
element. Such interactions might involve the Sp1 protein,
known to be a component of KBP (Kuhen and Samuel,
1999), or perhaps other yet unidentified protein constit-
uents of the KBP complex bound at the KCS element.
MATERIALS AND METHODS
Construction of reporter gene plasmids
The pCAT-Basic promoterless plasmid (Promega) con-
taining the CAT gene was used for construction of re-
porter plasmids containing the KCS and ISRE elements
of the human PKR promoter. The human PKR promoter
constructs p63 (Wt) and p63 (delK) were as previously
described (Kuhen and Samuel, 1999). These constructs
were used as the parent plasmids to generate mutants
with alterations in the spacing, orientation, and dosage
of the KCS element. Sequences of the double-stranded
oligonucleotides used to generate constructions with
synthetic inserts were as follows (mutations are indi-
cated in underlined type):
wild-type KCS:
5 CTGCAGGGAAGGCGGAGTCCAAGG 3;
mutant KCS(mt6A):
5 CTGCAGGGAAAGCGGAGTCCAAGG 3;
mutant KCS(mt9T):
5 CTGCAGGGAAGGCTGAGTCCAAGG 3.
To generate the 11-bp insertion mutation, the KCS ele-
ment was introduced into the blunted HindIII site of p63
(delK). Introduction of the KCS element in the reverse
orientation resulted in the orientation mutation in the
background of 15 bp of spacing between KCS and ISRE.
Insertions of 93 and 181 bp were generated by introduc-
tion of blunted pBluescript (Stratagene) HinfI (nts 1053–
1128) and DdeI (nts 1837–2003) restriction fragments,
respectively, into the blunted StyI site of the p63 (Kins11I)
insert in pBluescript, followed by introduction of the in-
sertion mutant into pCAT-Basic. Dosage mutants con-
taining three KCS elements in the p63 (Wt) background
were generated by introduction of either the wild-type or
the mutant 6A or 9T KCS element into the blunted PstI
site of the parent plasmid in a stepwise fashion to con-
serve the spacing of 4 bp between all copies of the KCS
element. Constructs containing three copies of the KCS
element, with the KCS element in the first position mu-
tated, were generated by introducing wild-type KCS ele-
ments into the p63 (KCSmt6A) or p63 (KCSmt9T) parent
plasmids as described above. The p63 (KCSmt6A) and
p63 (KCSmt9T) parent plasmids were derived from pre-
viously described mutant 503-bp Sa/Sa promoter con-
structs (Kuhen and Samuel, 1997) by insertion of a PstI–
XbaI fragment into pCAT-Basic. The structures of all PKR
promoter mutant constructions were confirmed by
Sanger sequencing.
Cell maintenance and interferon treatment
Human amnion U cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
5% (v/v) fetal bovine serum, 100 U/ml penicillin, and 100
g/ml streptomycin. Mouse embryo fibroblast cells were
maintained in the same medium supplemented with 10%
(v/v) fetal bovine serum and 1% sodium pyruvate (v/v).
Interferon treatment was carried out at 1000 U/ml IFN-
for 24 h in transient transfection analyses. For electro-
phoretic mobility shift assays (EMSA), MEF cells were
primed with 100 U/ml human IFN-A/D or mouse IFN-
(PBL) for 18 h, followed by treatment with 1000 U/ml
IFN-A/D for 30 min.
Transfection and reporter analyses
U cells were transfected by the DEAE-dextran-chloro-
quine phosphate transfection method (Luthman and
Magnusson, 1983) using 10 g of the CAT reporter gene
construct and 5 g of pGL2-Control (Promega) as the
internal reference plasmid. The pCAT-Control (Promega)
plasmid containing the simian virus 40 promoter and
enhancer and the promoterless pCAT-Basic plasmid
were routinely analyzed in all transfection experiments
for the purpose of comparison. All DNA plasmids used in
transfections were purified by cesium chloride equilib-
rium centrifugation and were analyzed by agarose gel
electrophoresis to verify plasmid integrity. Treatment with
IFN- was carried out 24 h posttransfection. Cells were
harvested 48 h posttransfection and extracts prepared by
repeated freeze–thaw cycles, followed by analysis of lucif-
erase activity according to instructions provided by the
manufacturer (Promega) and CAT activity as previously de-
scribed (Kuhen and Samuel, 1997; George and Samuel,
1999). The protein concentration of extracts was deter-
mined by the modified Bradford method (Bio-Rad). CAT
activity was quantified after thin-layer chromatography by
use of a Bio-Rad GS-525 molecular imager system.
Nuclear extract preparation
Nuclear extracts were prepared from MEF cells ac-
cording to published procedures (Bromberg et al., 1999).
Cells were scraped into ice-cold phosphate-buffered sa-
line and pelleted. Cell pellets were suspended in 3 vol
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lysis buffer [20 mM HEPES, pH 7.9; 10 mM KCl; 1 mM
EDTA, pH 8.0; 0.2% NP-40 (v/v); 0.1 mM Na3VO4; 1 mM
PMSF; 1 mM DTT; 10% glycerol (v/v); and 1% protease
inhibitor cocktail (v/v; Sigma)] and incubated on ice for 10
min. Cell suspensions were gently pipetted up and down
to ensure complete lysis of cells, and then lysates were
centrifuged at 14,000  g for 5 min at 4°C to obtain
nuclear pellets. Nuclear pellets were washed two times
with cell lysis buffer [minus NP-40 and minus protease
inhibitor cocktail] and then resuspended in 2 vol nuclear
extract buffer [20 mM HEPES, pH 7.9; 10 mM KCl; 1 mM
EDTA, pH 8.0; 1 mM PMSF; 1 mM DTT; 1 mM Na3VO4;
420 mM NaCl; 20% glycerol (v/v); and 10% protease
inhibitor cocktail (v/v; Sigma)]. Nuclei were extracted for
30 min at 4°C with gentle agitation, followed by centrif-
ugation at 14,000  g for 5 min at 4°C to obtain nuclear
extracts. Protein concentrations were determined by the
modified Bradford method (Bio-Rad).
Electrophoretic mobility shift assay
The sequences of the wild-type KCS, mutant KCS(mt6A),
and mutant KCS(mt9T) oligonucleotides used as double-
stranded, 32P-end-labeled probes or unlabeled competitors
were as described above under the plasmid construction
section. The sequences of the wild-type ISRE and KCS/
ISRE oligonucleotides used as the double-stranded probes
or competitors in EMSA analysis were 5CCAAGGG-
GAAAACGAAACTGCAG 3 and 5CTGCAGGGAAGGCGG
AGTCCAAGGGGAAAACGAAACTGCAG 3, respectively.
For protein–DNA binding reactions, 10 g of nuclear extract
protein was incubated with 32P-labeled probe for 25 min at
room temperature in a 25 l reaction containing 1 g
poly(dI-dC); 20 mM HEPES, pH 7.9; 1 mM MgCl2; 40 mM
KCl; 0.1 mMEGTA, pH 8.0; 1 mMDTT; and 10% glycerol (v/v).
Samples were analyzed by electrophoresis on 5% native
polyacrylamide gels with 0.5 Tris–borate–EDTA. Gels
were prerun at 4°C for at least 30 min prior to sample
loading, and electrophoresis was carried out for approxi-
mately 2 h 30 min. Gels were then dried and autoradiogra-
phy performed. For supershift analyses, antibodies against
STAT1/ and CBP were used (M-22 and 451, respectively,
Santa Cruz Biotechnology). Incubation with antibodies was
on ice for 45 min prior to addition of 32P-labeled probe.
Materials
Unless otherwise specified, all materials and reagents
were as described previously (Kuhen and Samuel, 1997,
1999; Kuhen et al., 1998). Mouse embryo fibroblasts, both
wild-type (STAT1/) and homozygous null mutant cells
deficient in STAT1 protein (STAT1/), were generously
provided by R. Schreiber (Meraz et al., 1996; Rodig et al.,
1998).
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